Exploratory Study of MSLN-CAR T Cells Secreting PD1/CTLA-4 Nanoantibody for the Treatment of Advanced Solid Tumors

NCT06248697 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

BIOLOGICAL: αPD1/CTLA4-MSLN-CAR T cells

Sponsor

Shanghai Cell Therapy Group Co.,Ltd